Andy AI vs Lime Health AI (2026)
Two home health documentation records built on the same insight, that the artifact is a federally mandated assessment rather than a note. Andy structures everything around that assessment, drafting it end to end with wound and medication documentation, a quality pass over the history and a genuine write back into the record system. Lime goes wider at the instrument level, covering the hospice evaluation as well as the home health assessment, with effectively complete coverage of post acute record systems and an oversight architecture that turns on the default: review is required rather than offered, and the trail is audit logged. For an agency running hospice alongside home health, Lime reaches a document Andy does not. For one focused purely on home health, Andy goes deeper into the assessment itself.
- It is structured around the federally mandated assessment end to end, drafting it alongside wound and medication documentation with a quality pass over the full history.
- The write back is genuine rather than a transfer step, so the completed chart including the assessment lands in the record system.
- A review gate is described at two distinct points, which is more than most of this segment offers for documentation that drives both payment and survey exposure.
- It is specialised at the level of the regulatory instrument, covering both the home health assessment and the hospice evaluation, which almost nothing else reaches.
- Coverage of the segment's record systems is effectively complete, which matters because agencies rarely change post acute platforms.
- Review is required by default rather than offered, with an audit logged trail and a stated signed business associate agreement, so oversight is enforced by the product rather than left to policy.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Andy AI and Lime Health AI are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Andy AI | Lime Health AI |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2023 | Not recorded |
| Headquarters | San Francisco, California | Not recorded |
| Website | with-andy.com | getlimeai.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Andy AI its top capability grade on AI Centrality. Set against Lime Health AI, Andy AI does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Its thinnest published disclosure sits on Model Supply Chain Disclosure and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Lime Health AI its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and EHR and Interoperability Depth. Set against Andy AI, Lime Health AI grades higher on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Andy AI or Lime Health AI?
The AI Health Index grades Lime Health AI higher than Andy AI on every axis that separates them, several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Andy AI does not grade higher on any scored axis.
Where do Andy AI and Lime Health AI differ most?
The widest separation the AI Health Index records between Andy AI and Lime Health AI is on Autonomy and Oversight Model, where Andy AI grades B and Lime Health AI grades A. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Andy AI and Lime Health AI grade the same?
The AI Health Index grades Andy AI and Lime Health AI the same on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Andy AI and Lime Health AI not disclosed?
At the last review, at least one of Andy AI and Lime Health AI published thin or absent detail on Model Supply Chain Disclosure and Security Certifications and Trust Center. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Home health documentation drives episode payment, which makes the coding incentive sharper here than anywhere else in this index, and neither vendor publishes an audit result showing that additional diagnoses were justified. Andy reports a case mix increase figure with no accuracy or audit measure beside it, which should be read as a commercial claim rather than a quality one. Neither publishes a full security attestation of the higher type, and neither publishes a subgroup analysis, which matters where assessments determine the level of care a patient receives at home.